Paper42210331
Expression of bluetongue virus core proteins VP2 and VP7 by bovine herpesvirus-4 confers protection against virulent challenge in a mouse model.
Franceschi V and 6 others. Vet Res, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Expression of bluetongue virus core proteins VP2 and VP7 by bovine herpesvirus-4 confers protection against virulent challenge in a mouse model. Papers, record 42210331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42210331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Expression of bluetongue virus core proteins VP2 and VP7 by bovine herpesvirus-4 confers protection against virulent challenge in a mouse model.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bluetongue | Major topic |
| Bluetongue virus | Major topic |
| Viral Vaccines | Major topic |
| Viral Core Proteins | Major topic |
| Herpesvirus 4, Bovine | Major topic |
| Animals | |
| Mice | |
| Mice, Inbred C57BL | |
| Female | |
| Capsid Proteins |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2022M2HP84 | Unione Europea-Next generation EU-PRIN-2022/PNRR | PubMed | ||
| PID2021-124872OB-100 | Ministerio de Ciencia, Innovación y Universidades | PubMed |
Source PubMed
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17267479 | Bluetongue virus entry into cells. | J Virol | 2007 | https://conductscience.org/library/papers/17267479 | PubMed |
| 2 | 22244980 | Myxomavirus as a vector for the immunisation of sheep: protection study against challenge with bluetongue virus. | Vaccine | 2012 | https://conductscience.org/library/papers/22244980 | PubMed |
| 3 | 21795358 | Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge. | J Virol | 2011 | https://conductscience.org/library/papers/21795358 | PubMed |
| 4 | 8001346 | The epidemiology of bluetongue. | Comp Immunol Microbiol Infect Dis | 1994 | https://conductscience.org/library/papers/8001346 | PubMed |
| 5 | 22687622 | Comparative analysis of Reoviridae reverse genetics methods. | Methods | 2013 | https://conductscience.org/library/papers/22687622 | PubMed |
| 6 | 38353566 | Engineering recombinant replication-competent bluetongue viruses expressing reporter genes for in vitro and non-invasive in vivo studies. | Microbiol Spectr | 2024 | https://conductscience.org/library/papers/38353566 | PubMed |
| 7 | 25858859 | An experimental subunit vaccine based on Bluetongue virus 4 VP2 protein fused to an antigen-presenting cells single chain antibody elicits cellular and humoral immune responses in cattle, guinea pigs and IFNAR(-/-) mice. | Vaccine | 2015 | https://conductscience.org/library/papers/25858859 | PubMed |
| 8 | 25680921 | Bluetongue disease and seroprevalence in South American camelids from the northwestern region of the United States. | J Vet Diagn Invest | 2015 | https://conductscience.org/library/papers/25680921 | PubMed |
| 9 | 24250214 | How to calculate sample size in animal studies? | J Pharmacol Pharmacother | 2013 | https://conductscience.org/library/papers/24250214 | PubMed |
| 10 | 21320537 | Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen. | Vaccine | 2011 | https://conductscience.org/library/papers/21320537 | PubMed |
| 11 | 39339950 | Increased Virulence of Culicoides Midge Cell-Derived Bluetongue Virus in IFNAR Mice. | Viruses | 2024 | https://conductscience.org/library/papers/39339950 | PubMed |
| 12 | 34594325 | Immunization With Bovine Herpesvirus-4-Based Vector Delivering PPRV-H Protein Protects Sheep From PPRV Challenge. | Front Immunol | 2021 | https://conductscience.org/library/papers/34594325 | PubMed |
| 13 | 39599497 | In Silico Development of a Multi-Epitope Subunit Vaccine against Bluetongue Virus in Ovis aries Using Immunoinformatics. | Pathogens | 2024 | https://conductscience.org/library/papers/39599497 | PubMed |
| 14 | 25013961 | Vaccination with recombinant adenoviruses expressing the peste des petits ruminants virus F or H proteins overcomes viral immunosuppression and induces protective immunity against PPRV challenge in sheep. | PLoS One | 2014 | https://conductscience.org/library/papers/25013961 | PubMed |
| 15 | 19148179 | Prospects for improved bluetongue vaccines. | Nat Rev Microbiol | 2009 | https://conductscience.org/library/papers/19148179 | PubMed |
| 16 | 19837295 | Bluetongue vaccines. | Vaccine | 2009 | https://conductscience.org/library/papers/19837295 | PubMed |
| 17 | 29556236 | Bovine Herpesvirus-4-Based Vector Delivering Peste des Petits Ruminants Virus Hemagglutinin ORF Induces both Neutralizing Antibodies and Cytotoxic T Cell Responses. | Front Immunol | 2018 | https://conductscience.org/library/papers/29556236 | PubMed |
| 18 | 39148262 | Bluetongue virus serotype 3 in ruminants in the Netherlands: Clinical signs, seroprevalence and pathological findings. | Vet Rec | 2024 | https://conductscience.org/library/papers/39148262 | PubMed |
| 19 | 33778041 | Vaccination With Recombinant Adenoviruses Expressing the Bluetongue Virus Subunits VP7 and VP2 Provides Protection Against Heterologous Virus Challenge. | Front Vet Sci | 2021 | https://conductscience.org/library/papers/33778041 | PubMed |
| 20 | 39765008 | Bluetongue virus serotype 12 in sheep and cattle in the Netherlands in 2024 - A BTV serotype reported in Europe for the first time. | Vet Microbiol | 2025 | https://conductscience.org/library/papers/39765008 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| IFNAR1 | 3454 | PubTator's text mining | https://conductscience.org/library/genes/3454 | NCBI Gene |
| IFNAR2 | 3455 | PubTator's text mining | https://conductscience.org/library/genes/3455 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| LAMP1 | 3916 | PubTator's text mining | https://conductscience.org/library/genes/3916 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42210331
GET https://conductscience.org/api/papers/v1/42210331/references?page=2